Literature DB >> 16985996

Prostate cancer pathology, screening, and epidemiology.

E D Crawford, G J Miller, F Labrie, D Hirano, J Batuello, L M Glodé.   

Abstract

Recent advances in the understanding of prostate cancer pathology, screening methods, and epidemiology were discussed at the 11th International Prostate Cancer Update. Regarding pathology, Dr. Gary Miller enumerated several factors that lead to the perception of prostate cancer as "unpredictable." These include the disease's multifocal nature, variable progression rates, and the uncertainty regarding the point at which carcinomas metastasize. Screening methods have been the subject of research by the Laval University Prostate Cancer Screening Program since 1988. Dr. Fernand Labrie presented the results of this 10-year study. Dr. Daisaku Hirano presented data from his studies of prostate cancer epidemiology in Japan as compared to the United States. The role of environmental factors, particularly diet, in prostate cancer pathogenesis and development is supported by the increase of the disease in Japan, concurrent with the "westernization" of diet there. Finally, useful information was presented on new computer- and Internet-based diagnostic and research tools.

Entities:  

Year:  2001        PMID: 16985996      PMCID: PMC1476077     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  16 in total

Review 1.  Nutrition and prostate cancer.

Authors:  L N Kolonel
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

2.  Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii.

Authors:  K Akazaki; G N Stemmerman
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

Review 3.  Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support.

Authors:  F Labrie
Journal:  Prostate       Date:  2000-05-15       Impact factor: 4.104

4.  The correlation of stage and pathology of prostate cancer in Japan.

Authors:  Y Kubota; K Imai; H Yamanaka
Journal:  Int J Urol       Date:  2000-04       Impact factor: 3.369

5.  Dietary and hormonal evaluation of men at different risks for prostate cancer: plasma and fecal hormone-nutrient interrelationships.

Authors:  D J Pusateri; W T Roth; J K Ross; T D Shultz
Journal:  Am J Clin Nutr       Date:  1990-03       Impact factor: 7.045

6.  Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

Authors:  B Candas; L Cusan; J L Gomez; P Diamond; R E Suburu; J Lévesque; G Brousseau; A Bélanger; F Labrie
Journal:  Prostate       Date:  2000-09-15       Impact factor: 4.104

7.  Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.

Authors:  F Labrie; B Candas; A Dupont; L Cusan; J L Gomez; R E Suburu; P Diamond; J Lévesque; A Belanger
Journal:  Prostate       Date:  1999-02-01       Impact factor: 4.104

8.  Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Authors:  F H Schröder; M Roobol-Bouts; A N Vis; T van der Kwast; R Kranse
Journal:  Urology       Date:  2001-01       Impact factor: 2.649

9.  Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer.

Authors:  F Lee; P J Littrup; L Loft-Christensen; B S Kelly; T A McHugh; D B Siders; A E Mitchell; J E Newby
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

10.  Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids.

Authors:  B A Evans; K Griffiths; M S Morton
Journal:  J Endocrinol       Date:  1995-11       Impact factor: 4.286

View more
  5 in total

1.  Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer.

Authors:  Matteo Sepulcri; Marco Fusella; Lea Cuppari; Alessandra Zorz; Marta Paiusco; Laura Evangelista
Journal:  Clin Transl Radiat Oncol       Date:  2021-07-27

2.  Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer.

Authors:  Nega Berhane; Rabinder Chandera Sobti; Shiferaw Melesse; Salih Abdul Mahdi; Afework Kassu
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

3.  Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Masashi Shinozaki; Nobutoshi Oka; Atsushi Takenaka; Isao Hara; Yosuke Matsumura; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

4.  The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.

Authors:  I Igerc; S Kohlfürst; H J Gallowitsch; S Matschnig; E Kresnik; I Gomez-Segovia; P Lind
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-11       Impact factor: 9.236

Review 5.  Reproductive tract biology: Of mice and men.

Authors:  Gerald R Cunha; Adriane Sinclair; Will A Ricke; Stanley J Robboy; Mei Cao; Laurence S Baskin
Journal:  Differentiation       Date:  2019-09-06       Impact factor: 3.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.